FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1512762132> ?p ?o ?g. }

• W1512762132 abstract "Abstract Background Pulmonary arterial hypertension is a proliferative vascular disease, characterized by aberrant regulation of smooth muscle cell proliferation and apoptosis in distal pulmonary arteries. Prostacyclin (PGI 2 ) analogues have anti-proliferative effects on distal human pulmonary artery smooth muscle cells (PASMCs), which are dependent on intracellular cAMP stimulation. We therefore sought to investigate the involvement of the main cAMP-specific enzymes, phosphodiesterase type 4 (PDE4), responsible for cAMP hydrolysis. Methods Distal human PASMCs were derived from pulmonary arteries by explant culture (n = 14, passage 3–12). Responses to platelet-derived growth factor-BB (5–10 ng/ml), serum, PGI 2 analogues (cicaprost, iloprost) and PDE4 inhibitors (roflumilast, rolipram, cilomilast) were determined by measuring cAMP phosphodiesterase activity, intracellular cAMP levels, DNA synthesis, apoptosis (as measured by DNA fragmentation and nuclear condensation) and matrix metalloproteinase-2 and -9 (MMP-2, MMP-9) production. Results Expression of all four PDE4A-D genes was detected in PASMC isolates. PDE4 contributed to the main proportion (35.9 ± 2.3%, n = 5) of cAMP-specific hydrolytic activity demonstrated in PASMCs, compared to PDE3 (21.5 ± 2.5%), PDE2 (15.8 ± 3.4%) or PDE1 activity (14.5 ± 4.2%). Intracellular cAMP levels were increased by PGI 2 analogues and further elevated in cells co-treated with roflumilast, rolipram and cilomilast. DNA synthesis was attenuated by 1 μM roflumilast (49 ± 6% inhibition), rolipram (37 ± 6%) and cilomilast (30 ± 4%) and, in the presence of 5 nM cicaprost, these compounds exhibited EC 50 values of 4.4 (2.6–6.1) nM (Mean and 95% confidence interval), 59 (36–83) nM and 97 (66–130) nM respectively. Roflumilast attenuated cell proliferation and gelatinase (MMP-2 and MMP-9) production and promoted the anti-proliferative effects of PGI 2 analogues. The cAMP activators iloprost and forskolin also induced apoptosis, whereas roflumilast had no significant effect. Conclusion PDE4 enzymes are expressed in distal human PASMCs and the effects of cAMP-stimulating agents on DNA synthesis, proliferation and MMP production is dependent, at least in part, on PDE4 activity. PDE4 inhibition may provide greater control of cAMP-mediated anti-proliferative effects in human PASMCs and therefore could prove useful as an additional therapy for pulmonary arterial hypertension." @default.
• W1512762132 created "2016-06-24" @default.
• W1512762132 creator A5027636877 @default.
• W1512762132 creator A5034538353 @default.
• W1512762132 creator A5046375247 @default.
• W1512762132 creator A5064279984 @default.
• W1512762132 creator A5070286094 @default.
• W1512762132 creator A5073698150 @default.
• W1512762132 date "2006-01-19" @default.
• W1512762132 modified "2023-10-17" @default.
• W1512762132 title "Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells" @default.
• W1512762132 cites W1567859570 @default.
• W1512762132 cites W1569338260 @default.
• W1512762132 cites W1943574501 @default.
• W1512762132 cites W1954701421 @default.
• W1512762132 cites W1971658736 @default.
• W1512762132 cites W1975224618 @default.
• W1512762132 cites W1977777133 @default.
• W1512762132 cites W1985429918 @default.
• W1512762132 cites W1986587470 @default.
• W1512762132 cites W1994226794 @default.
• W1512762132 cites W2001965102 @default.
• W1512762132 cites W2003697881 @default.
• W1512762132 cites W2007458222 @default.
• W1512762132 cites W2016285965 @default.
• W1512762132 cites W2018974548 @default.
• W1512762132 cites W2025593289 @default.
• W1512762132 cites W2042242996 @default.
• W1512762132 cites W2045486544 @default.
• W1512762132 cites W2058495945 @default.
• W1512762132 cites W2061902990 @default.
• W1512762132 cites W2082022155 @default.
• W1512762132 cites W2085739990 @default.
• W1512762132 cites W2093673373 @default.
• W1512762132 cites W2099621661 @default.
• W1512762132 cites W2104809729 @default.
• W1512762132 cites W2108332168 @default.
• W1512762132 cites W2110767986 @default.
• W1512762132 cites W2123066014 @default.
• W1512762132 cites W2126920991 @default.
• W1512762132 cites W2128937433 @default.
• W1512762132 cites W2129105000 @default.
• W1512762132 cites W2132622598 @default.
• W1512762132 cites W2142115399 @default.
• W1512762132 cites W2146914213 @default.
• W1512762132 cites W2147109610 @default.
• W1512762132 cites W2147812298 @default.
• W1512762132 cites W2147944062 @default.
• W1512762132 cites W2148557985 @default.
• W1512762132 cites W2148797779 @default.
• W1512762132 cites W2148965526 @default.
• W1512762132 cites W2150389145 @default.
• W1512762132 cites W2156431631 @default.
• W1512762132 cites W2157717113 @default.
• W1512762132 cites W2158324497 @default.
• W1512762132 cites W2158438681 @default.
• W1512762132 cites W2162908585 @default.
• W1512762132 cites W2165144526 @default.
• W1512762132 cites W2165474821 @default.
• W1512762132 cites W2176647628 @default.
• W1512762132 cites W2340048352 @default.
• W1512762132 cites W2341138542 @default.
• W1512762132 cites W2402014769 @default.
• W1512762132 cites W2411987749 @default.
• W1512762132 cites W51800425 @default.
• W1512762132 doi "https://doi.org/10.1186/1465-9921-7-9" @default.
• W1512762132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1386664" @default.
• W1512762132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16423283" @default.
• W1512762132 hasPublicationYear "2006" @default.
• W1512762132 type Work @default.
• W1512762132 sameAs 1512762132 @default.
• W1512762132 citedByCount "44" @default.
• W1512762132 countsByYear W15127621322012 @default.
• W1512762132 countsByYear W15127621322014 @default.
• W1512762132 countsByYear W15127621322015 @default.
• W1512762132 countsByYear W15127621322016 @default.
• W1512762132 countsByYear W15127621322017 @default.
• W1512762132 countsByYear W15127621322020 @default.
• W1512762132 countsByYear W15127621322021 @default.
• W1512762132 countsByYear W15127621322022 @default.
• W1512762132 crossrefType "journal-article" @default.
• W1512762132 hasAuthorship W1512762132A5027636877 @default.
• W1512762132 hasAuthorship W1512762132A5034538353 @default.
• W1512762132 hasAuthorship W1512762132A5046375247 @default.
• W1512762132 hasAuthorship W1512762132A5064279984 @default.
• W1512762132 hasAuthorship W1512762132A5070286094 @default.
• W1512762132 hasAuthorship W1512762132A5073698150 @default.
• W1512762132 hasBestOaLocation W15127621321 @default.
• W1512762132 hasConcept C126322002 @default.
• W1512762132 hasConcept C134018914 @default.
• W1512762132 hasConcept C155710745 @default.
• W1512762132 hasConcept C181199279 @default.
• W1512762132 hasConcept C2776766087 @default.
• W1512762132 hasConcept C2776780178 @default.
• W1512762132 hasConcept C2776958096 @default.
• W1512762132 hasConcept C2778926808 @default.
• W1512762132 hasConcept C2779395532 @default.
• W1512762132 hasConcept C2779739782 @default.
• W1512762132 hasConcept C2781103887 @default.
• W1512762132 hasConcept C2781128415 @default.

• next